AstraZeneca has revealed the data for Imfinzi in muscle-invasive bladder cancer (MIBC) that it hopes will be enough to secure FDA approval – although the jury is out on that. The clinical results of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback